DNA Script Overview
Pro stress-test →Founded in 2014 in Paris, DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science. The company is pioneering an alternative to traditional DNA synthesis called enzymatic DNA synthesis (EDS), making this technology accessible to labs with the world's first benchtop enzymatic synthesis instrument, SYNTAX™.
Strategic Profile
Pro stress-test →DNA Script is a leading company in manufacturing de novo synthetic nucleic acids using enzymatic DNA synthesis (EDS) technology, aiming to accelerate innovation in life science and technology through the decentralization of rapid, on demand and high-quality DNA synthesis. The company operates with a significant global footprint, anchored by its dual headquarters in Le Kremlin-Bicêtre (Paris area), France, and South San Francisco, California, USA.
Competitive Landscape
Pro stress-test →Competitors of DNA Script include Evonetix, Nuclera, Oxford Nanopore Technologies, Integrated DNA Technologies, and Eurofins Genomics Europe Shared Services. The enzymatic DNA synthesis market features both specialized startups and established life sciences instrument/reagent providers competing on speed, cost, and accessibility of benchtop DNA synthesis.
Industry Context
DNA Script operates in Enzymatic DNA synthesis instruments.
Key facts
Founded: 2014 · Headquarters: Paris, France · Employees: 132